With the rapid growth of the antibody-drug conjugates (ADCs) a GlobalData webinar outlined how to address these issues in expanding supply chains.

Thanks to modern therapies, a cancer diagnosis is no longer an automatic death sentence. But many patients still suffer from unwanted side effects and limited efficacy. In a recent Bioconjugate ...